Sort by
Refine Your Search
-
platform against haematological and solid cancers - CAR-NK 2.0" (Ref: 2023111086) of the Biobizkaia Health Research Institute. Requirements Research FieldMedical sciences » Health sciencesEducation LevelPhD
-
and prospects for immunotherapy against relapsed or refractory haematological cancers. Phase I clinical trial to assess the feasibility and safety of allogeneic CD19-CAR-NK therapy for patients with
-
will be within the framework of the project SpaceClones, whose objective is to develop high-throughput and spatial perturbation assays to understand on how cancer cell clones spatially organize to drive
Searches related to cancer
Enter an email to receive alerts for cancer positions